Arkolith/Insider Trading/KROS/Form 4

Knowles Julius

DirectorKeros Therapeutics, Inc. (KROS) · full profile →Form 4 · filed Jun 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$28K
Net Open-Market Flow
-$28K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 4, 2026Sell(S)3K$10.73$28K11K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808365-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML